Tag: immunotherapy
FDA Wants More Viaskin Peanut Data Resulting in Further Approval Delays
Delays mount pushing trials of modified patch.
Company Receives $1.9 Million Grant to Advance Microneedle Patch Therapy for...
Grant will allow Moonlight Therapeutics to complete pre-clinical activities and submit and IND to the FDA.
New Microneedle Patch Therapy for Food Allergies Takes Step Forward
Painless microneedle patch may provide new method for desensitization.
Peanut Sublingual Immunotherapy Provides Desensitization to Peanut in Toddlers
Study shows this therapy could be an option for early peanut allergy intervention.
Toothpaste Therapy for Food Allergies Takes Another Step Forward
FDA accepts IND application by Intrommune Therapeutics.
A Message for Food Allergy Sufferers: Now is Not the Time
Two common sense recommendations until the coronavirus crisis abates.
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”
Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate
"This study indicates a paradigm shift by addressing peanut allergy via a vaccination concept instead of classic desensitisation..."
DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut...
If approved, Viaskin Peanut would be the first and only epicutaneous immunotherapy indicated for this potentially life-threatening condition in children.
New Peanut Allergy Treatment Passes Phase 2 Trial, Shows Effectiveness and...
UNC School of Medicine researchers show that tiny under-the-tongue doses of peanut protein can offer safe and substantial protection against peanut allergy.
